Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2013-09-30
2017-12-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Imaging Comparison for the Preoperative Planning and Diagnosis of DIE: a Multicenter Retrospective Study.
NCT06994091
ENDOMED: Evaluation of the Evolution of Endometriosis Lesions on Imaging Under Medical Treatment
NCT05722314
ENDOMETRIOSIS - MRI
NCT05779462
Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions
NCT07053982
PET/MRI for Evaluation of Endometriosis
NCT06377553
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with endometriosis
Women with endometriosis with the intention of surgery - no intervention
No intervention
Evaluation of an imaging technique ic MRI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Evaluation of an imaging technique ic MRI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Didier Bielen, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospitals KULeuven
Elvier Mussen, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospitals KULeuven
Carla Tomassetti, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospitals KULeuven
Christel Meuleman, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospitals KULeuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospitals KULeuven
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S54441
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.